132 related articles for article (PubMed ID: 279399)
1. Selective destruction of human leukemic cells by alkyl-lysophospholipids.
Andreesen R; Modolell M; Weltzien HU; Eibl H; Common HH; Löhr GW; Munder PG
Cancer Res; 1978 Nov; 38(11 Pt 1):3894-9. PubMed ID: 279399
[No Abstract] [Full Text] [Related]
2. Studies on various parameters influencing leukemic cell destruction by alkyl-lysophospholipids.
Andreesen R; Modolell M; Oepke GH; Common H; Löhr GW; Munder PG
Anticancer Res; 1982; 2(1-2):95-100. PubMed ID: 7114806
[TBL] [Abstract][Full Text] [Related]
3. Effect of alkyl-lysophospholipids on phosphatidylcholine biosynthesis in leukemic cell lines.
Vogler WR; Whigham E; Bennett WD; Olson AC
Exp Hematol; 1985 Aug; 13(7):629-33. PubMed ID: 3861326
[TBL] [Abstract][Full Text] [Related]
4. Disturbance of phospholipid metabolism during the selective destruction of tumor cells induced by alkyl-lysophospholipids.
Modolell M; Andreesen R; Pahlke W; Brugger U; Munder PG
Cancer Res; 1979 Nov; 39(11):4681-6. PubMed ID: 498095
[TBL] [Abstract][Full Text] [Related]
5. Amygdalin (Laetrile): effect on clonogenic cells from human myeloid leukemia cell lines and normal human marrow.
Koeffler HP; Lowe L; Golde DW
Cancer Treat Rep; 1980 Jan; 64(1):105-9. PubMed ID: 6929726
[TBL] [Abstract][Full Text] [Related]
6. Metabolism of 1-beta-D-arabinofuranosylcytosine in human leukemic cells.
Chou TC; Arlin Z; Clarkson BD; Phillips FS
Cancer Res; 1977 Oct; 37(10):3561-70. PubMed ID: 332337
[No Abstract] [Full Text] [Related]
7. Cytotoxicity of thioether-lysophospholipids in leukemias and tumors of human origin.
Berdel WE; Fromm M; Fink U; Pahlke W; Bicker U; Reichert A; Rastetter J
Cancer Res; 1983 Nov; 43(11):5538-43. PubMed ID: 6577950
[TBL] [Abstract][Full Text] [Related]
8. Induction of differentiation of cultured human and mouse myeloid leukemia cells by alkyl-lysophospholipids.
Honma Y; Kasukabe T; Hozumi M; Tsushima S; Nomura H
Cancer Res; 1981 Aug; 41(8):3211-6. PubMed ID: 6941852
[TBL] [Abstract][Full Text] [Related]
9. Effects of alkyl-lysophospholipids on human leukemic cell lines measured by nuclear magnetic resonance.
Long RC; Small WC; Brynes RK; Tidwell T; Goldstein JH; Vogler WR
Cancer Res; 1983 Feb; 43(2):770-5. PubMed ID: 6571718
[TBL] [Abstract][Full Text] [Related]
10. Temperature dependence of leukemic cell destruction by alkyl-lysophospholipids (NSC 324368).
Andreesen R; Modolell M; Oepke GH; Munder PG
Exp Hematol; 1983 Jul; 11(6):564-70. PubMed ID: 6617791
[TBL] [Abstract][Full Text] [Related]
11. Difference in effects of alkyl-lysophospholipids and verapamil on vincristine transport in vincristine-sensitive and -resistant human myelogenous leukemia K562.
Tsuruo T; Saito H
Anticancer Res; 1987; 7(1):39-43. PubMed ID: 3471174
[TBL] [Abstract][Full Text] [Related]
12. Effects of tetrahydrouridine on the uptake and metabolism of 1-beta-D-arabinofuranosylcytosine in human normal and leukemic cells.
Ho DH; Carter CJ; Brown NS; Hester J; McCredie K; Benjamin RS; Freireich EJ; Bodey GP
Cancer Res; 1980 Jul; 40(7):2444-6. PubMed ID: 6248205
[No Abstract] [Full Text] [Related]
13. Perturbation of the generation cycle of human leukemic blast cells in vivo by vincristine.
Ernst P
Biomedicine; 1973 Nov; 18(6):484-90. PubMed ID: 4522355
[No Abstract] [Full Text] [Related]
14. Toxic effects of alkyl-lysophospholipids on human bone marrow and de novo leukaemias. A short overview.
Wötzel M; Brachwitz H; Langen P; Thierbach V
Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(6):771-6. PubMed ID: 1713880
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxicity of alkyl-lysophospholipid derivatives and low-alkyl-cleavage enzyme activities in rat brain tumor cells.
Berdel WE; Greiner E; Fink U; Stavrou D; Reichert A; Rastetter J; Hoffman DR; Snyder F
Cancer Res; 1983 Feb; 43(2):541-5. PubMed ID: 6848177
[TBL] [Abstract][Full Text] [Related]
16. Sensitivity of leukemia cell lines to cytotoxic alkyl-lysophospholipids in relation to O-alkyl cleavage enzyme activities.
Unger C; Eibl H; Kim DJ; Fleer EA; Kötting J; Bartsch HH; Nagel GA; Pfizenmaier K
J Natl Cancer Inst; 1987 Feb; 78(2):219-22. PubMed ID: 3468284
[TBL] [Abstract][Full Text] [Related]
17. Modes of uptake of methotrexate by normal and leukemic human leukocytes in vitro and their relation to drug response.
Kessel D; Hall TC; Roberts D
Cancer Res; 1968 Mar; 28(3):564-70. PubMed ID: 5238559
[No Abstract] [Full Text] [Related]
18. The effect of alkyl-lysophospholipids on tritiated thymidine incorporation and clonogenicity in vitro of normal and leukemic human cells.
Vogler WR; Whigham EA; Somberg LB; Long RC; Winton EF
Exp Hematol; 1984 Aug; 12(7):569-74. PubMed ID: 6540197
[TBL] [Abstract][Full Text] [Related]
19. Purging leukemia remission marrows with alkyl-lysophospholipids, preclinical and clinical results.
Vogler WR; Olson AC; Berdel WE; Okamoto S; Glasser L
Prog Clin Biol Res; 1990; 333():1-18; discussion 19-20. PubMed ID: 2308973
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the cytotoxic effects of merocyanine-540 on leukemic cells and normal human bone marrow.
Atzpodien J; Gulati SC; Clarkson BD
Cancer Res; 1986 Oct; 46(10):4892-5. PubMed ID: 3756850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
